alpha Clopenthixol,
alpha-Clopenthixol,
Cisordinol,
Clopenthixol,
Zuclopenthixol,
Zuclopenthixol,
Clopixol,
53772-83-1,
Zuclopentixol,
Cisordinol,
Zuclopenthixolum,
Zuclopentixol [Spanish],
Zuclopenthixolum [Latin],
cis-Clopenthixol,
Acuphase,
Clopentixol cis-(Z)-,
Zuclopenthixol dihydrochloride,
UNII-47ISU063SG,
Zuclopenthixol hydrochloride,
EINECS 258-758-5,
47ISU063SG,
CHEBI:51364,
Clopixol (TN),
(Z)-4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol,
2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol,
Chlorpenthixol,
Clopenthixolum,
C22H25ClN2OS,
MLS002154089,
NSC 64087,
(Z)-Clopenthixol,
NSC329015,
982-24-1,
SMR001233397,
Zuclopenthixol [BAN:INN],
Zuclopenthixol [INN:BAN],
cis(Z)-cloflupentixol,
Clopenthixol (USAN),
Zuclopenthixol (INN),
AC1NSKQX,
Prestwick2_000998,
Prestwick3_000998,
BSPBio_001095,
CHEMBL53904,
SCHEMBL149463,
4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol,
BPBio1_001205,
GTPL7559,
4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol,
BDBM79209,
CHEBI:59115,
cid_25102584,
ZINC601293,
HY-A0163,
PDSP1_001122,
PDSP2_001106,
AKOS015856353,
DB01624,
NCGC00179306-01,
LS-175496,
AB00514719,
CS-0017495,
D02613,
D03556,
BRD-K00198051-003-01-9,
BRD-K28761384-003-03-6,
UNII-0A432D932A component WFPIAZLQTJBIFN-DVZOWYKESA-N,
4-[3-[(9Z)-2-Chloro-9H-thioxanthene-9-ylidene]propyl]-1-piperazineethanol,
(Z)-2-(4-(3-(2-chloro-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethan-1-ol,
1-Piperazineethanol, 4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-,
2-(4-{3-[(9Z)-2-CHLORO-9H-THIOXANTHEN-9-YLIDENE]PROPYL}PIPERAZIN-1-YL)ETHAN-1-OL,
2-[4-[(3Z)-3-(2-chloranylthioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;hydrochloride,
2-[4-[(3Z)-3-(2-chloro-9-thioxanthenylidene)propyl]-1-piperazinyl]ethanol;hydrochloride,
2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;hydrochloride,
2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazino]ethanol;hydrochloride,
2-{4-[3-(2-chloro-10H-dibenzo[b,e]thiopyran-10-ylidene)propyl]piperazin-1-yl}ethanol,
2-{4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazin-1-yl}ethan-1-ol,
2-{4-[(3Z)-3-(2-chloro-10H-dibenzo[b,e]thiopyran-10-ylidene)propyl]piperazin-1-yl}ethanol,
CLOPENTHIXOL,
Clopentixol,
Zuclopenthixol HCl,
Zuclopenthixol acetate,
Zuclopenthixol decanoate,
C22H25ClN2OS.2ClH,
cis-Clopenthixol hydrochloride,
UNII-7042692VYN,
alpha-Clopenthixol dihydrochloride,
C22-H25-Cl-N2-O-S,
EINECS 261-080-2,
NSC169185,
C22-H25-Cl-N2-O-S.2Cl-H,
CID5311507,
Clopenthixol cis(Z)-form dihydrochloride,
2-(4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol,
(Z)-4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)-1-piperazineethanol dihydrochloride,
(Z)-4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride,
1-Piperazineethanol, 4-(3-(2-chloro-9H-thioxanthen-9-ylidene)propyl)-, (Z)-,
58045-23-1,